hsa-mir-2052: Hsa-mir-2052 is a microRNA that has been identified as having a strong link with various entities. According to a study, the target score values indicate the strongest associations between UBA2 and hsa-miR-133a-3p, hsa-miR-133b, GLO1 and hsa-miR-561-5p, STATH and hsa-miR-137-3p, hsa-miR-580-3p, and TUFT1 and hsa-miR-1233-3p [PMC9389532]. The expression of hsa-mir-2052 has been found to be significantly higher in ovarian cancer samples compared to control samples [PMC9389532]. Hsa-mir-2052 has been shown to bind to the S segment of various viruses belonging to Clade A NW [PMC7709035]. Additionally, it has been found that both hsa-mir-2052 and hsa-mir410–5p interact with RA, while hsa-mir676–3p and hsa-mir4693–3p interact with SLE and T1D. These miRNAs have been identified as common miRNAs that target multiple viral proteins in SARS-CoV-2 [PMC9259025]. Hsa-mir2052 has also been implicated in non-small cell lung cancer as a downregulated response to SOX2 and a potential candidate for chemoresistant therapy [PMC9259025]. Furthermore, miRNAs including hsa-miR365a–3p, hsamir2052, hsamiR3065–3p have been predicted for gene ADM [PMC9260904]. The regulatory network analysis revealed that several miRNAs including hsamir2052 interact with both ORF1ab and spike proteins of the virus [PMC8197616]. Lastly, miRNAs such as hsa-mir2052 have been predicted to target genes such as CYP1A1, CYP1B1, C7, ADCY2, SERPINB5, and ANAPC13 [PMC7473858].